Media Coverage

‘Pharmaleads seeks funds for dual enkephalinase inhibitors’

Pharmaleads’ Head of Clinical Research, Tanja Ouimet, Ph.D. to present at SMI Pain Therapeutics, London, on Tuesday, May 23, 2017

http://www.openpr.com/news/491836/Enhancing-Endogenous-Opioid-Concentrations-as-a-Novel-Treatment-for-Severe-Pain.html

Diabète: un nouveau traitement antidouleur à l’étude

L’hôpital de Lyon sud teste ce médicament qui pourrait soigner les douleurs neuropathiques dans plusieurs maladies/ The Lyon sud hospital is testing this drug which could treat neuropathic pain in various diseases

Older posts

Page 1 of 212
Discover our publications
Press & media coverage
Contact & find us

Pharmaleads SA
11, rue Watt
75013 Paris

Tel: +33 (0)1 44 06 70 00
Fax: +33 (0)1 44 06 60 99
info@pharmaleads.com

Get the access map